Literature DB >> 88606

Combined management of malignant teratoma of the testis.

M J Peckham, T J McElwain, A Barrett, W F Hendry.   

Abstract

Intensive chemotherapy with bleomycin and vinblastine was used as initial treatment in patients with advanced testicular teratoma and after relapse following lymph-node irradiation in patients with early-stage disease. Between January, 1976, and March, 1978, 84 patients, 28 with early disease and 56 with advanced disease, were treated. All 28 men with early-stage disease are alive and disease-free. Patients with advanced disease were divided into two groups. Patients with bulky multiple lung metastases and those with liver involvement did poorly, only 4 of 23 (17.4%) being disease-free. Conversely, patients with bulky abdominal nodes and those with limited lung disease did well, 17 of 21 previously untreated patients (80.9%) being alive and disease-free. Within the latter group, 16 patients were managed with chemotherapy and radiotherapy and/or surgery. Of these, 15 (93.4%) are disease-free.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88606     DOI: 10.1016/s0140-6736(79)90288-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  45 in total

1.  Chemotherapy for non-seminomatous germ-cell tumours.

Authors:  P M Wilkinson
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Low back pain and testicular cancer.

Authors:  R P Cole
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

3.  Testicular germ cell tumours--a model for a new approach to treatment of adult solid tumours.

Authors:  R T Oliver
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

4.  Rare cancers and specialist centres.

Authors:  R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

5.  Delay in diagnosing testicular tumours.

Authors:  W G Jones; I Appleyard
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

6.  [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. II. Long-term results of a study with 140 patients with retroperitoneal disease (stage II) (author's transl)].

Authors:  M E Scheulen; W Bierbaum; N Niederle; H U Eickenberg; H Holfeld; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1980-08-15

7.  Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.

Authors:  Mette Sprauten; Thomas H Darrah; Derick R Peterson; M Ellen Campbell; Robyn E Hannigan; Milada Cvancarova; Clair Beard; Hege S Haugnes; Sophie D Fosså; Jan Oldenburg; Lois B Travis
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

Review 8.  Good-risk-advanced germ cell tumors: historical perspective and current standards of care.

Authors:  Darren R Feldman; Robert J Motzer
Journal:  World J Urol       Date:  2009-06-10       Impact factor: 4.226

9.  Relation between bone erosions and rheumatoid factor isotypes.

Authors:  J A Arnason; T Jónsson; A Brekkan; K Sigurjónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

10.  Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Authors:  Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik A Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.